FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Henry Sarau

Research Profile

Living Beings

Chemicals & Drugs

Concepts & Ideas

Physiology

Binding, Competitive

Procedures

Anatomy

Genes & Molecular Sequences

Amino Acid Sequences

Co-author Network

Publications

TOP 3
Michael Salmon; Henry M Sarau; Dulcie B Schmidt; Robert J Slack; Edward F Webb; Victoria J Barrett; Peter T Buckley; Miriam Burman; Christopher J Dehaas; James J Foley; Douglas W P Hay; Charles J Kotzer; Dramane I Lainé; Mark A Luttmann; Michael R Palovich; William L Rumsey
Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases.
Qi Jin; Michael R Palovich; Michael Salmon; Henry M Sarau; Dulcie B Schmidt; Yonghui Wang; Edward F Webb; Katherine L Widdowson; Kristen E Belmonte; Peter T Buckley; Ann M Bullion; Roderick S Davis; James J Foley; Jian Jin; Jakob Busch-Petersen
Tyrosine urea muscarinic acetylcholine receptor antagonists: achiral quaternary ammonium groups.
Dramane I Lainé; Philip S Landis; Mark A Luttmann; Michael R Palovich; Brian J Peck; Michael Salmon; Henry M Sarau; Dulcie B Schmidt; Sandra T Umbrecht; Zehong Wan; Edward F Webb; Katherine L Widdowson; Haibo Xie; Hongxing Yan; Roderick S Davis; Jeremy Dufour; James J Foley; Gerald E Hunsberger; Alicia M Bacon; Miriam Burman; Jakob Busch-Petersen
Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Henry Sarau (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Michael Salmon; Henry M Sarau; Dulcie B Schmidt; Robert J Slack; Edward F Webb; Victoria J Barrett; Peter T Buckley; Miriam Burman; Christopher J Dehaas; James J Foley; Douglas W P Hay; Charles J Kotzer; Dramane I Lainé; Mark A Luttmann; Michael R Palovich; William L Rumsey
Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases.
The Journal of pharmacology and experimental therapeutics 2013;345(2):260-70.
2012: Qi Jin; Michael R Palovich; Michael Salmon; Henry M Sarau; Dulcie B Schmidt; Yonghui Wang; Edward F Webb; Katherine L Widdowson; Kristen E Belmonte; Peter T Buckley; Ann M Bullion; Roderick S Davis; James J Foley; Jian Jin; Jakob Busch-Petersen
Tyrosine urea muscarinic acetylcholine receptor antagonists: achiral quaternary ammonium groups.
Bioorganic & medicinal chemistry letters 2012;22(23):7087-91.
2012: Dramane I Lainé; Philip S Landis; Mark A Luttmann; Michael R Palovich; Brian J Peck; Michael Salmon; Henry M Sarau; Dulcie B Schmidt; Sandra T Umbrecht; Zehong Wan; Edward F Webb; Katherine L Widdowson; Haibo Xie; Hongxing Yan; Roderick S Davis; Jeremy Dufour; James J Foley; Gerald E Hunsberger; Alicia M Bacon; Miriam Burman; Jakob Busch-Petersen
Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.
Bioorganic & medicinal chemistry letters 2012;22(9):3366-9.
2009: Dramane I Lainé; Zehong Wan; Hongxing Yan; Chongjie Zhu; Haibo Xie; Wei Fu; Jakob Busch-Petersen; Christopher Neipp; Roderick Davis; Katherine L Widdowson; Frank E Blaney; James Foley; Alicia M Bacon; Edward F Webb; Mark A Luttmann; Miriam Burman; Henry M Sarau; Michael Salmon; Michael R Palovich; Kristen Belmonte
Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.
Journal of medicinal chemistry 2009;52(16):5241-52.
2009: Zehong Wan; Dramane I Laine; Hongxing Yan; Chongjie Zhu; Katherine L Widdowson; Peter T Buckley; Miriam Burman; James J Foley; Henry M Sarau; Dulcie B Schmidt; Edward F Webb; Kristen E Belmonte; Michael Palovich
Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.
Bioorganic & medicinal chemistry letters 2009;19(16):4560-2.
2009: Brian Budzik; Yonghui Wang; Dongchuan Shi; Feng Wang; Haibo Xie; Zehong Wan; Chongye Zhu; James J Foley; Parvathi Nuthulaganti; Lorena A Kallal; Henry M Sarau; Dwight M Morrow; Michael L Moore; Ralph A Rivero; Michael Palovich; Michael Salmon; Kristen E Belmonte; Dramane I Laine; Jian Jin
M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.
Bioorganic & medicinal chemistry letters 2009;19(6):1686-90.
2009: Yonghui Wang; Jakob Busch-Petersen; Feng Wang; Terence J Kiesow; Todd L Graybill; Jian Jin; Zheng Yang; James J Foley; Gerald E Hunsberger; Dulcie B Schmidt; Henry M Sarau; Elizabeth A Capper-Spudich; Zining Wu; Laura S Fisher; Michael S McQueney; Ralph A Rivero; Katherine L Widdowson
Camphor sulfonamide derivatives as novel, potent and selective CXCR3 antagonists.
Bioorganic & medicinal chemistry letters 2009;19(1):114-8.
2008: Jian Jin; Yonghui Wang; Dongchuan Shi; Feng Wang; Wei Fu; Roderick S Davis; Qi Jin; James J Foley; Henry M Sarau; Dwight M Morrow; Michael L Moore; Ralph A Rivero; Michael Palovich; Michael Salmon; Kristen E Belmonte; Jakob Busch-Petersen
Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.
Bioorganic & medicinal chemistry letters 2008;18(20):5481-6.
2008: Jian Jin; Brian Budzik; Yonghui Wang; Dongchuan Shi; Feng Wang; Haibo Xie; Zehong Wan; Chongye Zhu; James J Foley; Edward F Webb; Manuela Berlanga; Miriam Burman; Henry M Sarau; Dwight M Morrow; Michael L Moore; Ralph A Rivero; Michael Palovich; Michael Salmon; Kristen E Belmonte; Dramane I Lainé
Discovery of biphenyl piperazines as novel and long acting muscarinic acetylcholine receptor antagonists.
Journal of medicinal chemistry 2008;51(19):5915-8.
2008: Jian Jin; Yonghui Wang; Dongchuan Shi; Feng Wang; Roderick S Davis; Qi Jin; Wei Fu; James J Foley; Edward F Webb; Chris J Dehaas; Manuela Berlanga; Miriam Burman; Henry M Sarau; Dwight M Morrow; Parvathi Rao; Lorena A Kallal; Michael L Moore; Ralph A Rivero; Michael Palovich; Michael Salmon; Kristen E Belmonte; Jakob Busch-Petersen
Discovery of novel and long acting muscarinic acetylcholine receptor antagonists.
Journal of medicinal chemistry 2008;51(16):4866-9.
2008: Jian Jin; Ming An; Anthony Sapienza; Nambi Aiyar; Diane Naselsky; Henry M Sarau; James J Foley; Kevin L Salyers; Steven D Knight; Richard M Keenan; Ralph A Rivero; Dashyant Dhanak; Stephen Douglas
Urotensin-II receptor antagonists: synthesis and SAR of N-cyclic azaalkyl benzamides.
Bioorganic & medicinal chemistry letters 2008;18(14):3950-4.
2007: Yonghui Wang; Jakob Busch-Petersen; Feng Wang; Lanping Ma; Wei Fu; Jeffrey K Kerns; Jian Jin; Michael R Palovich; Jing-Kang Shen; Miriam Burman; James J Foley; Dulcie B Schmidt; Gerald E Hunsberger; Henry M Sarau; Katherine L Widdowson
3-Arylamino-2H-1,2,4-benzothiadiazin-5-ol 1,1-dioxides as novel and selective CXCR2 antagonists.
Bioorganic & medicinal chemistry letters 2007;17(14):3864-7.
2007: Jian Jin; Yonghui Wang; Feng Wang; Jeffery K Kerns; Victoria M Vinader; Ashley P Hancock; Matthew J Lindon; Graeme I Stevenson; Dwight M Morrow; Parvathi Rao; Cuc Nguyen; Victoria J Barrett; Chris Browning; Guido Hartmann; David Andrew; Henry M Sarau; James J Foley; Anthony Jurewicz; James A Fornwald; Andy J Harker; Michael L Moore; Ralph A Rivero; Kristen E Belmonte; Helen E Connor
Oxazolidinones as novel human CCR8 antagonists.
Bioorganic & medicinal chemistry letters 2007;17(6):1722-5.
2007: Brent W McCleland; Roderick S Davis; Michael R Palovich; Katherine L Widdowson; Michelle L Werner; Miriam Burman; James J Foley; Dulcie B Schmidt; Henry M Sarau; Martin Rogers; Kevin L Salyers; Peter D Gorycki; Theresa J Roethke; Gary J Stelman; Leonard M Azzarano; Keith W Ward; Jakob Busch-Petersen
Comparison of N,N'-diarylsquaramides and N,N'-diarylureas as antagonists of the CXCR2 chemokine receptor.
Bioorganic & medicinal chemistry letters 2007;17(6):1713-7.
2007: Grant C Nicholson; Rachel C Tennant; Donald C Carpenter; Henry M Sarau; Onn Min Kon; Peter J Barnes; Michael Salmon; Rupert S Vessey; Ruth Tal-Singer; Trevor T Hansel
A novel flow cytometric assay of human whole blood neutrophil and monocyte CD11b levels: upregulation by chemokines is related to receptor expression, comparison with neutrophil shape change, and effects of a chemokine receptor (CXCR2) antagonist.
Pulmonary pharmacology & therapeutics 2007;20(1):52-9.
2006: Hong Nie; Katherine L Widdowson; Michael R Palovich; Wei Fu; John D Elliott; Deborah L Bryan; Miriam Burman; Dulcie B Schmidt; James J Foley; Henry M Sarau; Jakob Busch-Petersen
N,N'-Diarylcyanoguanidines as antagonists of the CXCR2 and CXCR1 chemokine receptors.
Bioorganic & medicinal chemistry letters 2006;16(21):5513-6.
2006: David J Behm; Gerald Stankus; Christopher P A Doe; Robert N Willette; Henry M Sarau; James J Foley; Dulcie B Schmidt; Parvathi Nuthulaganti; James A Fornwald; Robert S Ames; David G Lambert; Girolamo Calo'; Valeria Camarda; Nambi Aiyar; Stephen Douglas
The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems.
British journal of pharmacology 2006;148(2):173-90.
2005: Jian Jin; Dashyant Dhanak; Steven D Knight; Katherine L Widdowson; Nambi Aiyar; Diane Naselsky; Henry M Sarau; James J Foley; Dulcie B Schmidt; Carl D Bennett; Bing Wang; Gregory L Warren; Michael L Moore; Richard M Keenan; Ralph A Rivero; Stephen Douglas
Aminoalkoxybenzyl pyrrolidines as novel human urotensin-II receptor antagonists.
Bioorganic & medicinal chemistry letters 2005;15(13):3229-32.
2005: Stephen Douglas; David J Behm; Nambi Aiyar; Diane Naselsky; Jyoti Disa; David P Brooks; Eliot ohlstein; John G Gleason; Henry M Sarau; James J Foley; Peter T Buckley; Dulcie B Schmidt; William E Wixted; Katherine L Widdowson; Graham Riley; Jian Jin; Timothy F Gallagher; Stanley J Schmidt; Lance H Ridgers; Lisa T Christmann; Richard M Keenan; Steven D Knight; Dashyant Dhanak
Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375.
British journal of pharmacology 2005;145(5):620-35.
2005: Nambi Aiyar; Douglas G Johns; Zhaohui Ao; Jyoti Disa; David J Behm; James J Foley; Peter T Buckley; Henry M Sarau; Harjeet K van-der-Keyl; Nabil A Elshourbagy; Stephen Douglas
Cloning and pharmacological characterization of the cat urotensin-II receptor (UT).
Biochemical pharmacology 2005;69(7):1069-79.
2004: Eric N Johnson; Edward R Appelbaum; Donald C Carpenter; Richard Cox; Jyoti Disa; James J Foley; Sujoy K Ghosh; Diane P Naselsky; Mark A Pullen; Henry M Sarau; Samuel R Scheff; Klaudia Steplewski; Meirav Zaks-Zilberman; Nambi Aiyar
Neuromedin U elicits cytokine release in murine Th2-type T cell clone D10.G4.1.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(12):7230-8.
2004: Jane E Gartlon; Philip G Szekeres; Mark A Pullen; Henry M Sarau; Nambi Aiyar; Usman Shabon; David Michalovich; Klaudia Steplewski; Cathy Ellis; Nabil A Elshourbagy; Mark S Duxon; Tracey E Ashmeade; David C Harrison; Paul R Murdock; Shelagh Wilson; Abdel Ennaceur; Alan R Atkins; Christian A Heidbreder; James Hagan; A Jackie Hunter; Declan N C Jones
Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats.
Psychopharmacology 2004;177(1-2):1-14.
2004: Qi Jin; Hong Nie; Brent W McCleland; Katherine L Widdowson; Michael R Palovich; John D Elliott; Richard M Goodman; Miriam Burman; Henry M Sarau; Keith W Ward; Melanie Nord; Bonnie M Orr; Peter D Gorycki; Jakob Busch-Petersen
Discovery of potent and orally bioavailable N,N'-diarylurea antagonists for the CXCR2 chemokine receptor.
Bioorganic & medicinal chemistry letters 2004;14(17):4375-8.
2004: Sreekumar Pillai; Diane J Cousens; Ashley A Barnes; Peter T Buckley; Mathias N Chiano; Louise K Hosking; Lee-Ann Cameron; Mary E Fling; James J Foley; Andrew Green; Henry M Sarau; Dulcie B Schmidt; Catherine S Sprankle; Malcolm N Blumenthal; Jørgen Vestbo; Karen Kennedy-Wilson; William E Wixted; Michael J Wagner; Wayne H Anderson; Diane M Ignar
A coding polymorphism in the CYSLT2 receptor with reduced affinity to LTD4 is associated with asthma.
Pharmacogenetics 2004;14(9):627-33.
2004: Nambi Aiyar; Jyoti Disa; James J Foley; Peter T Buckley; William E Wixted; Mark A Pullen; Usman Shabon; Edward Dul; Philip G Szekeres; Nabil A Elshourbagy; Henry M Sarau; Edward R Appelbaum; Jane Bolaky
Radioligand binding and functional characterization of recombinant human NmU1 and NmU2 receptors stably expressed in clonal human embryonic kidney-293 cells.
Pharmacology 2004;72(1):33-41.
2004: Katherine L Widdowson; John D Elliott; Daniel F Veber; Hong Nie; Melvin C Rutledge; Brent W McCleland; Jia-Ning Xiang; Anthony Jurewicz; Robert P Hertzberg; James J Foley; Don E Griswold; Lenox Martin; Judithann M Lee; John White; Henry M Sarau
Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptor.
Journal of medicinal chemistry 2004;47(6):1319-21.
2004: Sigrid P Matzer; Julie Zombou; Henry M Sarau; Martin Röllinghoff; H Ulrich Beuscher
A synthetic, non-peptide CXCR2 antagonist blocks MIP-2-induced neutrophil migration in mice.
Immunobiology 2004;209(3):225-33.
2004: Elizabeth L Hardaker; Alicia M Bacon; Karey Carlson; Amy K Roshak; James J Foley; Dulcie B Schmidt; Peter T Buckley; Meghan Comegys; Reynold A Panettieri; Henry M Sarau; Kristen E Belmonte
Regulation of TNF-alpha- and IFN-gamma-induced CXCL10 expression: participation of the airway smooth muscle in the pulmonary inflammatory response in chronic obstructive pulmonary disease.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(1):191-3.
2003: Christopher L Herold; David J Behm; Peter T Buckley; James J Foley; William E Wixted; Henry M Sarau; Stephen Douglas
The neuromedin B receptor antagonist, BIM-23127, is a potent antagonist at human and rat urotensin-II receptors.
British journal of pharmacology 2003;139(2):203-7.
2003: Bysani Chandrasekar; Peter C Melby; Henry M Sarau; Muthuswamy Raveendran; Rao P Perla; Federica M Marelli-Berg; Nickolai O Dulin; Ishwar S Singh
Chemokine-cytokine cross-talk. The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway.
The Journal of biological chemistry 2003;278(7):4675-86.
2002: Patricia L Podolin; Brian J Bolognese; James J Foley; Dulcie B Schmidt; Peter T Buckley; Katherine L Widdowson; Qi Jin; John White; Judithann M Lee; Richard B Goodman; Tonja R Hagen; Osamu Kajikawa; Lisa A Marshall; Douglas W P Hay; Henry M Sarau
A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbit.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(11):6435-44.
2002: Douglas W P Hay; Giuseppe A M Giardina; Don E Griswold; David C Underwood; Charles J Kotzer; Brian Bush; William Potts; Punam Sandhu; Dave Lundberg; James J Foley; Dulcie B Schmidt; Lenox D Martin; David Kilian; Jeffrey J Legos; Frank C Barone; Mark A Luttmann; Mario Grugni; Luca F Raveglia; Henry M Sarau
Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs.
The Journal of pharmacology and experimental therapeutics 2002;300(1):314-23.
2001: K Freeman; Ping Tsui; Darren J Moore; P C Emson; L Vawter; S Naheed; P Lane; H Bawagan; Nicole C Herrity; K Murphy; Henry M Sarau; Robert S Ames; Shelagh Wilson; George P Livi; Jon K Chambers
Cloning, pharmacology, and tissue distribution of G-protein-coupled receptor GPR105 (KIAA0001) rodent orthologs.
Genomics 2001;78(3):124-8.
2001: Philippe Robert; Ping Tsui; M P Laville; George P Livi; Henry M Sarau; Antoine Bril; Isabelle Berrebi-Bertrand
EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes.
Journal of molecular and cellular cardiology 2001;33(9):1589-606.
2001: Alison I Muir; L Chamberlain; Nabil A Elshourbagy; David Michalovich; Darren J Moore; A Calamari; Philip G Szekeres; Henry M Sarau; Jon K Chambers; Paul R Murdock; Klaudia Steplewski; Usman Shabon; JE Miller; S E Middleton; J G Darker; C G Larminie; Shelagh Wilson; DJ Bergsma; Piers C Emson; R Faull; KL Philpott; David C Harrison
AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1.
The Journal of biological chemistry 2001;276(31):28969-75.
2001: Dashyant Dhanak; Lisa T Christmann; Michael G Darcy; Richard M Keenan; Steven D Knight; J Lee; Lance H Ridgers; Henry M Sarau; DH Shah; John White; Lihua Zhang
Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2.
Bioorganic & medicinal chemistry letters 2001;11(11):1445-50.
2001: Dashyant Dhanak; Lisa T Christmann; Michael G Darcy; Anthony Jurewicz; Richard M Keenan; J Lee; Henry M Sarau; Katherine L Widdowson; John White
Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1.
Bioorganic & medicinal chemistry letters 2001;11(11):1441-4.
2001: Douglas W P Hay; Henry M Sarau
Interleukin-8 receptor antagonists in pulmonary diseases.
Current opinion in pharmacology 2001;1(3):242-7.
2001: F E Blaney; Luca F Raveglia; M Artico; S Cavagnera; C Dartois; Carlo Farina; Mario Grugni; Stefania Gagliardi; Mark A Luttmann; M Martinelli; GM Nadler; Carlo Parini; Paola Petrillo; Henry M Sarau; Mark A Scheideler; Douglas W P Hay; Giuseppe A M Giardina
Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists.
Journal of medicinal chemistry 2001;44(11):1675-89.
2001: Robert S Ames; D Lee; James J Foley; Anthony Jurewicz; Mark A Tornetta; Wilfried Bautsch; Britta Settmacher; Andreas Klos; Karl F Erhard; Russell D Cousins; Anthony C Sulpizio; J Paul Hieble; Gerald P McCafferty; Keith W Ward; Jerry L Adams; WE Bondinell; David C Underwood; RR Osborn; AM Badger; Henry M Sarau
Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(10):6341-8.
2001: Yuan Zhu; David Michalovich; H Wu; Kong B Tan; GM Dytko; Ishrat J Mannan; Rogely Boyce; J Alston; Lauren A Tierney; X Li; Nicole C Herrity; L Vawter; Henry M Sarau; Robert S Ames; C M Davenport; J Paul Hieble; Shelagh Wilson; DJ Bergsma; LR Fitzgerald
Cloning, expression, and pharmacological characterization of a novel human histamine receptor.
Molecular pharmacology 2001;59(3):434-41.
2001: Henry M Sarau; JA Feild; Robert S Ames; James J Foley; Parvathi Nuthulaganti; Dulcie B Schmidt; Peter T Buckley; Nabil A Elshourbagy; ME Brawner; Mark A Luttmann; Giuseppe A M Giardina; Douglas W P Hay
Molecular and pharmacological characterization of the murine tachykinin NK(3) receptor.
European journal of pharmacology 2001;413(2-3):143-50.
2000: Stephen Douglas; Anthony C Sulpizio; V Piercy; Henry M Sarau; Robert S Ames; Nambi Aiyar; Eliot ohlstein; Robert N Willette
Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey.
British journal of pharmacology 2000;131(7):1262-74.
2000: John White; Judithann M Lee; K Dede; CS Imburgia; Anthony Jurewicz; G Chan; James A Fornwald; Dashyant Dhanak; Lisa T Christmann; Michael G Darcy; Katherine L Widdowson; James J Foley; Dulcie B Schmidt; Henry M Sarau
Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration.
The Journal of biological chemistry 2000;275(47):36626-31.
2000: Henry M Sarau; Don E Griswold; B Bush; William Potts; P Sandhu; D Lundberg; James J Foley; Dulcie B Schmidt; Edward F Webb; Lenox D Martin; Jeffrey J Legos; R G Whitmore; Frank C Barone; Andrew D Medhurst; Mark A Luttmann; Giuseppe A M Giardina; Douglas W P Hay
Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist.
The Journal of pharmacology and experimental therapeutics 2000;295(1):373-81.
2000: Henry M Sarau; J L Mooney; Dulcie B Schmidt; James J Foley; Peter T Buckley; Giuseppe A M Giardina; D Y Wang; J A Lee; Douglas W P Hay
Evidence that the proposed novel human "neurokinin-4" receptor is pharmacologically similar to the human neurokinin-3 receptor but is not of human origin.
Molecular pharmacology 2000;58(3):552-9.
2000: Nabil A Elshourbagy; Robert S Ames; LR Fitzgerald; James J Foley; Jon K Chambers; Philip G Szekeres; Nicholas A Evans; Dulcie B Schmidt; Peter T Buckley; GM Dytko; Paul R Murdock; Graeme Milligan; DA Groarke; Kong B Tan; Usman Shabon; Parvathi Nuthulaganti; D Y Wang; Shelagh Wilson; DJ Bergsma; Henry M Sarau
Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor.
The Journal of biological chemistry 2000;275(34):25965-71.
2000: LR Fitzgerald; GM Dytko; Henry M Sarau; Ishrat J Mannan; C Ellis; P A Lane; Kong B Tan; Paul R Murdock; Shelagh Wilson; DJ Bergsma; Robert S Ames; James J Foley; D A Campbell; LJ McMillan; N Evans; Nabil A Elshourbagy; H Minehart; Ping Tsui
Identification of an EDG7 variant, HOFNH30, a G-protein-coupled receptor for lysophosphatidic acid.
Biochemical and biophysical research communications 2000;273(3):805-10.
2000: Xinkang Wang; X Li; Dulcie B Schmidt; James J Foley; Frank C Barone; Robert S Ames; Henry M Sarau
Identification and molecular characterization of rat CXCR3: receptor expression and interferon-inducible protein-10 binding are increased in focal stroke.
Molecular pharmacology 2000;57(6):1190-8.
2000: R A Johanson; Henry M Sarau; James J Foley; JR Slemmon
Calmodulin-binding peptide PEP-19 modulates activation of calmodulin kinase II In situ.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2000;20(8):2860-6.
2000: Jon K Chambers; L E Macdonald; Henry M Sarau; Robert S Ames; K Freeman; James J Foley; Yuan Zhu; Megan M McLaughlin; Paul R Murdock; LJ McMillan; John J Trill; A Swift; Nambi Aiyar; P Taylor; L Vawter; S Naheed; Philip G Szekeres; Guillaume J Hervieu; C Scott; J M Watson; Andrew J Murphy; E Duzic; C Klein; DJ Bergsma; Shelagh Wilson; George P Livi
A G protein-coupled receptor for UDP-glucose.
The Journal of biological chemistry 2000;275(15):10767-71.
1999: JA Feild; James J Foley; T T Testa; Parvathi Nuthulaganti; C Ellis; Henry M Sarau; Robert S Ames
Cloning and characterization of a rabbit ortholog of human Galpha16 and mouse G(alpha)15.
FEBS letters 1999;460(1):53-6.
1999: Robert S Ames; Henry M Sarau; Jon K Chambers; Robert N Willette; Nambi Aiyar; Anne M Romanic; CS Louden; James J Foley; Charles F Sauermelch; Robert W Coatney; Zhaohui Ao; Jyoti Disa; S D Holmes; JM Stadel; J D Martin; W S Liu; G I Glover; Shelagh Wilson; Dean E McNulty; CE Ellis; Nabil A Elshourbagy; Usman Shabon; John J Trill; Douglas W P Hay; Eliot ohlstein; DJ Bergsma; Stephen Douglas
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14.
Nature 1999;401(6750):282-6.
1999: Henry M Sarau; Robert S Ames; J Chambers; C Ellis; Nabil A Elshourbagy; James J Foley; Dulcie B Schmidt; RM Muccitelli; O Jenkins; Paul R Murdock; Nicole C Herrity; WS Halsey; Ganesh Sathe; Alison I Muir; Parvathi Nuthulaganti; GM Dytko; Peter T Buckley; Shelagh Wilson; DJ Bergsma; Douglas W P Hay
Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor.
Molecular pharmacology 1999;56(3):657-63.
1999: Xinkang Wang; X Li; Shoshanit Yaish-Ohad; Henry M Sarau; Frank C Barone; Giora Z Feuerstein
Molecular cloning and expression of the rat monocyte chemotactic protein-3 gene: a possible role in stroke.
Brain research. Molecular brain research 1999;71(2):304-12.
1999: J Chambers; Robert S Ames; DJ Bergsma; A Muir; LR Fitzgerald; Guillaume J Hervieu; GM Dytko; James J Foley; J Martin; W S Liu; J Park; C Ellis; S Ganguly; S Konchar; Jane E Cluderay; R Leslie; Shelagh Wilson; Henry M Sarau
Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1.
Nature 1999;400(6741):261-5.
1999: Henry M Sarau; James J Foley; Dulcie B Schmidt; Lenox D Martin; Edward F Webb; MN Tzimas; JJ Breton; MC Chabot-Fletcher; David C Underwood; Douglas W P Hay; W D Kingsbury; PA Chambers; Israil Pendrak; D R Jakas; Ganesh Sathe; S Van Horn; Robert A Daines; Don E Griswold
In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity.
Prostaglandins, leukotrienes, and essential fatty acids 1999;61(1):55-64.
1999: Giuseppe A M Giardina; M Artico; S Cavagnera; Alberto Cerri; E Consolandi; Stefania Gagliardi; D Graziani; Mario Grugni; Douglas W P Hay; Mark A Luttmann; R Mena; Luca F Raveglia; R Rigolio; Henry M Sarau; Dulcie B Schmidt; G Zanoni; Carlo Farina
Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonists.
Farmaco (Società chimica italiana : 1989) 1999;54(6):364-74.
1999: T Crass; Robert S Ames; Henry M Sarau; Mark A Tornetta; James J Foley; Jörg Köhl; Andreas Klos; Wilfried Bautsch
Chimeric receptors of the human C3a receptor and C5a receptor (CD88).
The Journal of biological chemistry 1999;274(13):8367-70.
1999: Giuseppe A M Giardina; Luca F Raveglia; Mario Grugni; Henry M Sarau; Carlo Farina; Andrew D Medhurst; D Graziani; Dulcie B Schmidt; R Rigolio; Mark A Luttmann; S Cavagnera; James J Foley; V Vecchietti; Douglas W P Hay
Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412).
Journal of medicinal chemistry 1999;42(6):1053-65.
1998: Stefan Lienenklaus; Robert S Ames; Mark A Tornetta; Henry M Sarau; James J Foley; T Crass; Bettina Sohns; U Raffetseder; Melanie Grove; A Hölzer; Andreas Klos; Jörg Köhl; Wilfried Bautsch
Human anaphylatoxin C4a is a potent agonist of the guinea pig but not the human C3a receptor.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(5):2089-93.
1998: John White; Judithann M Lee; Peter Young; R P Hertzberg; Anthony Jurewicz; M A Chaikin; Katherine L Widdowson; James J Foley; Lenox D Martin; Don E Griswold; Henry M Sarau
Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration.
The Journal of biological chemistry 1998;273(17):10095-8.
1997: Robert S Ames; Mark A Tornetta; James J Foley; T E Hugli; Henry M Sarau
Evidence that the receptor for C4a is distinct from the C3a receptor.
Immunopharmacology 1997;38(1-2):87-92.
1997: John White; CS Imburgia; Edward Dul; Edward R Appelbaum; K O'Donnell; DJ O'Shannessy; ME Brawner; James A Fornwald; John E Adamou; Nabil A Elshourbagy; K Kaiser; James J Foley; Dulcie B Schmidt; Kyung O Johanson; Colin H Macphee; Kitty E Moores; Dean E McNulty; Gilbert F Scott; R P Schleimer; Henry M Sarau
Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils.
Journal of leukocyte biology 1997;62(5):667-75.
1997: Henry M Sarau; J A Rush; James J Foley; ME Brawner; Dulcie B Schmidt; John White; Mary S Barnette
Characterization of functional chemokine receptors (CCR1 and CCR2) on EoL-3 cells: a model system to examine the role of chemokines in cell function.
The Journal of pharmacology and experimental therapeutics 1997;283(1):411-8.
1997: Theo A Berkhout; Henry M Sarau; Kitty E Moores; John White; Nabil A Elshourbagy; Edward R Appelbaum; R J Reape; ME Brawner; J Makwana; James J Foley; Dulcie B Schmidt; CS Imburgia; Dean E McNulty; J Matthews; K O'Donnell; DJ O'Shannessy; M Scott; Pieter Groot; Colin H Macphee
Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B.
The Journal of biological chemistry 1997;272(26):16404-13.
1997: Giuseppe A M Giardina; Henry M Sarau; Carlo Farina; Andrew D Medhurst; Mario Grugni; Luca F Raveglia; Dulcie B Schmidt; R Rigolio; Mark A Luttmann; V Vecchietti; Douglas W P Hay
Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 1. Identification of the 4-quinolinecarboxamide framework.
Journal of medicinal chemistry 1997;40(12):1794-807.
1997: Henry M Sarau; Don E Griswold; William Potts; James J Foley; Dulcie B Schmidt; Edward F Webb; Lenox D Martin; ME Brawner; Nabil A Elshourbagy; Andrew D Medhurst; Giuseppe A M Giardina; Douglas W P Hay
Nonpeptide tachykinin receptor antagonists: I. Pharmacological and pharmacokinetic characterization of SB 223412, a novel, potent and selective neurokinin-3 receptor antagonist.
The Journal of pharmacology and experimental therapeutics 1997;281(3):1303-11.
1997: Mark A Tornetta; James J Foley; Henry M Sarau; Robert S Ames
The mouse anaphylatoxin C3a receptor: molecular cloning, genomic organization, and functional expression.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(11):5277-82.
1996: R A Daines; P A Chambers; James J Foley; Don E Griswold; W D Kingsbury; Lenox D Martin; Dulcie B Schmidt; K K Sham; Henry M Sarau
(E)-3-[6-[[(2,6-dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2- pyridinyl]-2-propenoic acid: a high-affinity leukotriene B4 receptor antagonist with oral antiinflammatory activity.
Journal of medicinal chemistry 1996;39(19):3837-41.
1996: Robert S Ames; Y Li; Henry M Sarau; Parvathi Nuthulaganti; James J Foley; C Ellis; Z Zeng; K Su; Anthony Jurewicz; R P Hertzberg; DJ Bergsma; C Kumar
Molecular cloning and characterization of the human anaphylatoxin C3a receptor.
The Journal of biological chemistry 1996;271(34):20231-4.
1996: Giuseppe A M Giardina; Henry M Sarau; Carlo Farina; Andrew D Medhurst; Mario Grugni; James J Foley; Luca F Raveglia; Dulcie B Schmidt; R Rigolio; M Vassallo; V Vecchietti; Douglas W P Hay
2-Phenyl-4-quinolinecarboxamides: a novel class of potent and selective non-peptide competitive antagonists for the human neurokinin-3 receptor.
Journal of medicinal chemistry 1996;39(12):2281-4.
1995: Theodore J Torphy; H L Zhou; James J Foley; Henry M Sarau; C D Manning; Mary S Barnette
Salbutamol up-regulates PDE4 activity and induces a heterologous desensitization of U937 cells to prostaglandin E2. Implications for the therapeutic use of beta-adrenoceptor agonists.
The Journal of biological chemistry 1995;270(40):23598-604.
1995: MC Chabot-Fletcher; David C Underwood; JJ Breton; Jerry L Adams; A Kagey-Sobotka; Don E Griswold; Lisa A Marshall; Henry M Sarau; James D Winkler; Douglas W P Hay
Pharmacological characterization of SB 202235, a potent and selective 5-lipoxygenase inhibitor: effects in models of allergic asthma.
The Journal of pharmacology and experimental therapeutics 1995;273(3):1147-55.
1995: Henry M Sarau; James J Foley; Dulcie B Schmidt; MN Tzimas; Lenox D Martin; R A Daines; P A Chambers; W D Kingsbury; Don E Griswold
SB 209247, a high affinity LTB4 receptor antagonist demonstrating potent antiinflammatory activity.
Advances in prostaglandin, thromboxane, and leukotriene research 1995;23():275-7.
1994: Mary S Barnette; J Rush; Lisa A Marshall; James J Foley; Dulcie B Schmidt; Henry M Sarau
Effects of scalaradial, a novel inhibitor of 14 kDa phospholipase A2, on human neutrophil function.
Biochemical pharmacology 1994;47(9):1661-7.
1993: Jeffrey C Boehm; J G Gleason; I Pendrak; Henry M Sarau; Dulcie B Schmidt; James J Foley; W D Kingsbury
Synthesis and LTB4 receptor antagonist activities of the naturally occurring LTB4 receptor antagonist Leucettamine A and related analogues.
Journal of medicinal chemistry 1993;36(22):3333-40.
1993: R A Daines; P A Chambers; I Pendrak; Dalia R Jakas; Henry M Sarau; James J Foley; Dulcie B Schmidt; W D Kingsbury
Trisubstituted pyridine leukotriene B4 receptor antagonists: synthesis and structure-activity relationships.
Journal of medicinal chemistry 1993;36(22):3321-32.
1993: W D Kingsbury; I Pendrak; J D Leber; Jeffrey C Boehm; B Mallet; Henry M Sarau; James J Foley; Dulcie B Schmidt; R A Daines
Synthesis of structural analogs of leukotriene B4 and their receptor binding activity.
Journal of medicinal chemistry 1993;36(22):3308-20.
1993: R A Daines; P A Chambers; I Pendrak; Dalia R Jakas; Henry M Sarau; James J Foley; Dulcie B Schmidt; Don E Griswold; Lenox D Martin; MN Tzimas
(E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid: a novel high-affinity leukotriene B4 receptor antagonist.
Journal of medicinal chemistry 1993;36(18):2703-5.
1993: H L Zhou; MC Chabot-Fletcher; James J Foley; Henry M Sarau; MN Tzimas; James D Winkler; Theodore J Torphy
Association between leukotriene B4-induced phospholipase D activation and degranulation of human neutrophils.
Biochemical pharmacology 1993;46(1):139-48.
1992: Frank C Barone; Dulcie B Schmidt; L M Hillegass; W J Price; Ray F White; Giora Z Feuerstein; R K Clark; E V Lee; Don E Griswold; Henry M Sarau
Reperfusion increases neutrophils and leukotriene B4 receptor binding in rat focal ischemia.
Stroke; a journal of cerebral circulation 1992;23(9):1337-47; discussion 1347-8.
1992: Tian-Li Yue; JM Stadel; Henry M Sarau; E Friedman; Juan-li Gu; D A Powers; M M Gleason; Giora Feuerstein; H Y Wang
Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C.
Molecular pharmacology 1992;41(2):281-9.
1991: P J Marshall; Don E Griswold; J Breton; Edward F Webb; L M Hillegass; Henry M Sarau; J Newton; John Lee; P E Bender; N Hanna
Pharmacology of the pyrroloimidazole, SK&F 105809--I. Inhibition of inflammatory cytokine production and of 5-lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.
Biochemical pharmacology 1991;42(4):813-24.
1991: Frank C Barone; L M Hillegass; W J Price; Ray F White; E V Lee; Giora Z Feuerstein; Henry M Sarau; R K Clark; Don E Griswold
Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification.
Journal of neuroscience research 1991;29(3):336-45.
1991: Douglas W P Hay; R M Muccitelli; L M Vickery-Clark; L S Novak; RR Osborn; J G Gleason; L A Yodis; C M Saverino; R D Eckardt; Henry M Sarau
Pharmacologic and pharmacokinetic profile of SK&F S-106203, a potent, orally active peptidoleukotriene receptor antagonist, in guinea-pig.
Pulmonary pharmacology 1991;4(3):177-89.
1989: F L Stassen; Dulcie B Schmidt; M Papadopoulos; Henry M Sarau
Prolonged incubation with phorbol esters enhanced vasopressin-induced calcium mobilization and polyphosphatidylinositol hydrolysis of vascular smooth muscle cells.
The Journal of biological chemistry 1989;264(9):4916-23.
1989: J Paul Hieble; Anthony C Sulpizio; Henry M Sarau; K E Flaim; A L Blumberg; J P McCafferty; R L Zeid
SK&F 89124, a potent and selective agonist at prejunctional dopamine receptors.
Fundamental & clinical pharmacology 1989;3(6):621-42.
1988: S Mong; H L Wu; A Wong; Henry M Sarau; S T Crooke
Leukotriene D4 receptor-mediated phosphoinositol hydrolysis and calcium mobilization in rat basophilic leukemic cells.
The Journal of pharmacology and experimental therapeutics 1988;247(2):803-13.
1988: James D Winkler; Henry M Sarau; James J Foley; S T Crooke
Leukotriene D4-induced homologous desensitization in basal and differentiated U-937 cells: characterization with the partial agonist leukotriene E4 and assessment of receptor reserve.
The Journal of pharmacology and experimental therapeutics 1988;247(1):54-62.
1988: James D Winkler; Henry M Sarau; James J Foley; S Mong; S T Crooke
Leukotriene B4-induced homologous desensitization of calcium mobilization and phosphoinositide metabolism in U-937 cells.
The Journal of pharmacology and experimental therapeutics 1988;246(1):204-10.
1988: F L Stassen; G Heckman; D Schmidt; M T Papadopoulos; P Nambi; Henry M Sarau; N Aiyar; M Gellai; L Kinter
Oxytocin induces a transient increase in cytosolic free [Ca2+] in renal tubular epithelial cells: evidence for oxytocin receptors on LLC-PK1 cells.
Molecular pharmacology 1988;33(2):218-24.
1988: S T Crooke; S Mong; Henry M Sarau; James D Winkler; V K Vegesna
Mechanisms of regulation of receptors and signal transduction pathways for the peptidyl leukotrienes.
Annals of the New York Academy of Sciences 1988;524():153-61.
1987: Don E Griswold; P J Marshall; Edward F Webb; R Godfrey; J Newton; M J DiMartino; Henry M Sarau; J G Gleason; G Poste; N Hanna
SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.
Biochemical pharmacology 1987;36(20):3463-70.
1987: P J Fowler; A H Nelson; W J Price; Henry M Sarau; M Grous; D M Lombardi; Frank C Barone; H S Ormsbee
Effects of KC 2450 on the lower esophageal sphincter in vivo and in vitro.
European journal of pharmacology 1987;142(2):225-33.
1987: Stephen T Ross; R G Franz; G Gallagher; M Brenner; J W Wilson; R M DeMarinis; J Paul Hieble; Henry M Sarau
Dopamine agonists related to 3-allyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzaz epi ne-7, 8-diol. 6-Position modifications.
Journal of medicinal chemistry 1987;30(1):35-40.
1986: J Weinstock; D L Ladd; J W Wilson; C K Brush; N C Yim; G Gallagher; M E McCarthy; J Silvestri; Henry M Sarau; K E Flaim
Synthesis and renal vasodilator activity of some dopamine agonist 1-aryl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diols: halogen and methyl analogues of fenoldopam.
Journal of medicinal chemistry 1986;29(11):2315-25.
1986: J Weinstock; D E Gaitanopoulos; H J Oh; F R Pfeiffer; C B Karash; J W Venslavsky; Henry M Sarau; K E Flaim; J Paul Hieble; C Kaiser
Synthesis and dopaminergic activity of some halogenated mono- and dihydroxylated 2-aminotetralins.
Journal of medicinal chemistry 1986;29(9):1615-27.
1986: Stephen T Ross; R G Franz; J W Wilson; M Brenner; R M DeMarinis; J Paul Hieble; Henry M Sarau
Dopamine receptor agonists: 3-allyl-6-chloro-2,3,4,5-tetrahydro- 1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol and a series of related 3-benzazepines.
Journal of medicinal chemistry 1986;29(5):733-40.
1985: K E Flaim; G W Gessner; S T Crooke; Henry M Sarau; J Weinstock
Binding of a novel dopaminergic agonist radioligand [3H]-fenoldopam (SKF 82526) to D-1 receptors in rat striatum.
Life sciences 1985;36(15):1427-36.
1984: P A Dandridge; C Kaiser; M Brenner; D Gaitanopoulos; L D Davis; R L Webb; J J Foley; Henry M Sarau
Synthesis, resolution, absolute stereochemistry, and enantioselectivity of 3',4'-dihydroxynomifensine.
Journal of medicinal chemistry 1984;27(1):28-35.
1982: R A Hahn; J R Wardell; Henry M Sarau; P T Ridley
Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
The Journal of pharmacology and experimental therapeutics 1982;223(2):305-13.
1982: C Kaiser; P A Dandridge; E Garvey; R A Hahn; Henry M Sarau; P E Setler; L S Bass; J Clardy
Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine.
Journal of medicinal chemistry 1982;25(6):697-703.
1982: F R Pfeiffer; J W Wilson; J Weinstock; G Y Kuo; P A Chambers; K G Holden; R A Hahn; J R Wardell; A J Tobia; P E Setler; Henry M Sarau
Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines.
Journal of medicinal chemistry 1982;25(4):352-8.
1982: J Paul Hieble; Henry M Sarau; J J Foley; R M Demarinis; R G Pendleton
Comparison of central and peripheral alpha 1-adrenoceptors.
Naunyn-Schmiedeberg's archives of pharmacology 1982;318(4):267-73.
1980: J Weinstock; J W Wilson; D L Ladd; C K Brush; F R Pfeiffer; G Y Kuo; K G Holden; N C Yim; R A Hahn; J R Wardell; A J Tobia; P E Setler; Henry M Sarau; P T Ridley
Separation of potent central and renal dopamine agonist activity in substituted 6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepines.
Journal of medicinal chemistry 1980;23(9):973-5.
1980: C Kaiser; FE Ali; WE Bondinell; M Brenner; K G Holden; Thomas W Ku; H J Oh; Stephen T Ross; N C Yim; C L Zirkle; R A Hahn; Henry M Sarau; P E Setler; J R Wardell
6-(Phenylthio)-substituted 2,3,4,5-tetrahydro-1H-3-benzazepines, a novel class of dopamine receptor antagonists and neuroleptics.
Journal of medicinal chemistry 1980;23(9):975-6.